Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) α activity by ERβ in the uterus

Jonna Frasor, Daniel H. Barnett, Jeanne M. Danes, Rex A Hess, Albert F. Parlow, Benita S Katzenellenbogen

Research output: Contribution to journalArticle

Abstract

Estrogen is of great importance in the regulation of uterine function. The aim of this study was to examine the individual physiological roles of each of the two receptors for estradiol, estrogen receptor (ER) α and ERβ, and their potential co-modulatory effects on gene expression and uterine growth using recently developed ER subtype-selective agonist ligands. The use of ER subtype-selective ligands provides an alternative, complementary approach to the use of receptor knockout mice. Administration of the ERα-selective ligand propyl pyrazole triol (PPT) to immature mice resulted in a significant increase in uterine weight, as well as bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression in luminal epithelial cells. PPT also increased complement component 3, lactoferrin, and glucose-6-phosphate dehydrogenase (G6PDH), and decreased androgen receptor (AR) and progesterone receptor (PR) mRNA levels in uterine tissue, as did estradiol (E2). However, when compared with E2, PPT was less effective in stimulating uterine weight, complement component 3, and G6PDH expression but was as effective as E2 in regulating lactoferrin, AR, and PR expression. In contrast to the action of the ERα agonist PPT, the ERβ agonist diarylpropionitrile (DPN) did not increase uterine weight or luminal epithelial cell proliferation at a dose that reduced G6PDH and elicited a decrease in PR and AR mRNA and protein expression. Interestingly, DPN reduced the uterine weight stimulation by PPT, and enhanced the effect of PPT in decreasing uterine PR and AR mRNA. These findings with ER subtype-selective ligands indicate that ERα is the major regulator of estrogen function in the uterus, but that ERβ does exert effects on some uterine markers of estrogen action. In addition, ERβ can modulate ERα activity in a response-specific and dose-dependent manner.

Original languageEnglish (US)
Pages (from-to)3159-3166
Number of pages8
JournalEndocrinology
Volume144
Issue number7
DOIs
StatePublished - Jul 1 2003

Fingerprint

Estrogen Receptors
Uterus
Ligands
Androgen Receptors
Progesterone Receptors
Estrogens
Glucosephosphate Dehydrogenase
Weights and Measures
Complement C3
Messenger RNA
Epithelial Cells
Estradiol Receptors
Lactoferrin
Proliferating Cell Nuclear Antigen
Bromodeoxyuridine
Knockout Mice
1,3,5-tris(4-hydroxyphenyl)-4-propyl-1H-pyrazole
Estradiol
Cell Proliferation
Gene Expression

ASJC Scopus subject areas

  • Endocrinology

Cite this

Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) α activity by ERβ in the uterus. / Frasor, Jonna; Barnett, Daniel H.; Danes, Jeanne M.; Hess, Rex A; Parlow, Albert F.; Katzenellenbogen, Benita S.

In: Endocrinology, Vol. 144, No. 7, 01.07.2003, p. 3159-3166.

Research output: Contribution to journalArticle

Frasor, Jonna ; Barnett, Daniel H. ; Danes, Jeanne M. ; Hess, Rex A ; Parlow, Albert F. ; Katzenellenbogen, Benita S. / Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) α activity by ERβ in the uterus. In: Endocrinology. 2003 ; Vol. 144, No. 7. pp. 3159-3166.
@article{105a7c0670df4dc6a62b46250b79de0d,
title = "Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) α activity by ERβ in the uterus",
abstract = "Estrogen is of great importance in the regulation of uterine function. The aim of this study was to examine the individual physiological roles of each of the two receptors for estradiol, estrogen receptor (ER) α and ERβ, and their potential co-modulatory effects on gene expression and uterine growth using recently developed ER subtype-selective agonist ligands. The use of ER subtype-selective ligands provides an alternative, complementary approach to the use of receptor knockout mice. Administration of the ERα-selective ligand propyl pyrazole triol (PPT) to immature mice resulted in a significant increase in uterine weight, as well as bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression in luminal epithelial cells. PPT also increased complement component 3, lactoferrin, and glucose-6-phosphate dehydrogenase (G6PDH), and decreased androgen receptor (AR) and progesterone receptor (PR) mRNA levels in uterine tissue, as did estradiol (E2). However, when compared with E2, PPT was less effective in stimulating uterine weight, complement component 3, and G6PDH expression but was as effective as E2 in regulating lactoferrin, AR, and PR expression. In contrast to the action of the ERα agonist PPT, the ERβ agonist diarylpropionitrile (DPN) did not increase uterine weight or luminal epithelial cell proliferation at a dose that reduced G6PDH and elicited a decrease in PR and AR mRNA and protein expression. Interestingly, DPN reduced the uterine weight stimulation by PPT, and enhanced the effect of PPT in decreasing uterine PR and AR mRNA. These findings with ER subtype-selective ligands indicate that ERα is the major regulator of estrogen function in the uterus, but that ERβ does exert effects on some uterine markers of estrogen action. In addition, ERβ can modulate ERα activity in a response-specific and dose-dependent manner.",
author = "Jonna Frasor and Barnett, {Daniel H.} and Danes, {Jeanne M.} and Hess, {Rex A} and Parlow, {Albert F.} and Katzenellenbogen, {Benita S}",
year = "2003",
month = "7",
day = "1",
doi = "10.1210/en.2002-0143",
language = "English (US)",
volume = "144",
pages = "3159--3166",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "7",

}

TY - JOUR

T1 - Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) α activity by ERβ in the uterus

AU - Frasor, Jonna

AU - Barnett, Daniel H.

AU - Danes, Jeanne M.

AU - Hess, Rex A

AU - Parlow, Albert F.

AU - Katzenellenbogen, Benita S

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Estrogen is of great importance in the regulation of uterine function. The aim of this study was to examine the individual physiological roles of each of the two receptors for estradiol, estrogen receptor (ER) α and ERβ, and their potential co-modulatory effects on gene expression and uterine growth using recently developed ER subtype-selective agonist ligands. The use of ER subtype-selective ligands provides an alternative, complementary approach to the use of receptor knockout mice. Administration of the ERα-selective ligand propyl pyrazole triol (PPT) to immature mice resulted in a significant increase in uterine weight, as well as bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression in luminal epithelial cells. PPT also increased complement component 3, lactoferrin, and glucose-6-phosphate dehydrogenase (G6PDH), and decreased androgen receptor (AR) and progesterone receptor (PR) mRNA levels in uterine tissue, as did estradiol (E2). However, when compared with E2, PPT was less effective in stimulating uterine weight, complement component 3, and G6PDH expression but was as effective as E2 in regulating lactoferrin, AR, and PR expression. In contrast to the action of the ERα agonist PPT, the ERβ agonist diarylpropionitrile (DPN) did not increase uterine weight or luminal epithelial cell proliferation at a dose that reduced G6PDH and elicited a decrease in PR and AR mRNA and protein expression. Interestingly, DPN reduced the uterine weight stimulation by PPT, and enhanced the effect of PPT in decreasing uterine PR and AR mRNA. These findings with ER subtype-selective ligands indicate that ERα is the major regulator of estrogen function in the uterus, but that ERβ does exert effects on some uterine markers of estrogen action. In addition, ERβ can modulate ERα activity in a response-specific and dose-dependent manner.

AB - Estrogen is of great importance in the regulation of uterine function. The aim of this study was to examine the individual physiological roles of each of the two receptors for estradiol, estrogen receptor (ER) α and ERβ, and their potential co-modulatory effects on gene expression and uterine growth using recently developed ER subtype-selective agonist ligands. The use of ER subtype-selective ligands provides an alternative, complementary approach to the use of receptor knockout mice. Administration of the ERα-selective ligand propyl pyrazole triol (PPT) to immature mice resulted in a significant increase in uterine weight, as well as bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression in luminal epithelial cells. PPT also increased complement component 3, lactoferrin, and glucose-6-phosphate dehydrogenase (G6PDH), and decreased androgen receptor (AR) and progesterone receptor (PR) mRNA levels in uterine tissue, as did estradiol (E2). However, when compared with E2, PPT was less effective in stimulating uterine weight, complement component 3, and G6PDH expression but was as effective as E2 in regulating lactoferrin, AR, and PR expression. In contrast to the action of the ERα agonist PPT, the ERβ agonist diarylpropionitrile (DPN) did not increase uterine weight or luminal epithelial cell proliferation at a dose that reduced G6PDH and elicited a decrease in PR and AR mRNA and protein expression. Interestingly, DPN reduced the uterine weight stimulation by PPT, and enhanced the effect of PPT in decreasing uterine PR and AR mRNA. These findings with ER subtype-selective ligands indicate that ERα is the major regulator of estrogen function in the uterus, but that ERβ does exert effects on some uterine markers of estrogen action. In addition, ERβ can modulate ERα activity in a response-specific and dose-dependent manner.

UR - http://www.scopus.com/inward/record.url?scp=0037972896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037972896&partnerID=8YFLogxK

U2 - 10.1210/en.2002-0143

DO - 10.1210/en.2002-0143

M3 - Article

C2 - 12810572

AN - SCOPUS:0037972896

VL - 144

SP - 3159

EP - 3166

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 7

ER -